Beryl Drugs informs about financial results

14 Nov 2018 Evaluate

Pursuant to Regulation 30 read with Part- A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Beryl Drugs has informed that the Board of Directors in its Board Meeting held on November 13, 2018 has approved the Unaudited Financial Results of the company for the Quarter/ Half year ended 30th September, 2018.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

34.74 0.01 (0.03%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.